Soumon Rudra
Overview
Soumon Rudra, MD, is a radiation oncologist specializing in the treatment of head and neck cancer, and gastrointestinal cancer. He treats patients at Emory University Hospital Midtown and Emory Proton Therapy Center.
Dr. Rudra serves as associate director for the Department of Radiation Oncology's Physician Residency Program.
Dr. Rudra received his medical degree from Emory University School of Medicine in Atlanta, Georgia. He completed his residency in radiation oncology at Washington University School of Medicine in Saint Louis, Missouri, where he was Chief Resident in his final year of residency training.
Dr. Rudra's articles have been published in a number of leading journals including Advances in Radiation Oncology, Journal of Neuro-Oncology, and International Journal of Radiation Oncology, Biology, Physics.
Academic Appointment
- Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine
Education
Degrees
- MD from Emory University School of Medicine
Research
Publications
-
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J -
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
Head Neck Volume: 46 Page(s): 2167 - 2177
09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC -
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nat Med Volume: 30 Page(s): 2373
08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S -
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
JAMA Oncol Volume: 10 Page(s): 896 - 904
07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M -
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features.
Acta Oncol Volume: 62 Page(s): 627 - 634
06/01/2023 Authors: Bohannon D; Janopaul-Naylor J; Rudra S; Yang X; Chang CW; Wang Y; Ma C; Patel SA; McDonald MW; Zhou J -
Insurance Authorization and Access to Proton Therapy for Patients With Head and Neck Cancers.
Int J Radiat Oncol Biol Phys Volume: 116 Page(s): 404 - 412
06/01/2023 Authors: McDonald MW; Bates JE; McCall NS; Goyal S; Liu Y; Rudra S; Remick JS; Tian S; El-Deiry MW; Saba NF -
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nat Med Volume: 29 Page(s): 880 - 887
04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S -
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT).
Clin Transl Radiat Oncol Volume: 39 Page(s): 100561
03/01/2023 Authors: Schiff JP; Maraghechi B; Chin R-I; Price A; Laugeman E; Rudra S; Hatscher C; Spraker MB; Badiyan SN; Henke LE -
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities.
Head Neck Volume: 45 Page(s): 658 - 663
03/01/2023 Authors: Janopaul-Naylor JR; Rupji M; Tobillo RA; Lorenz JW; Switchenko JM; Tian S; Kaka AS; Qian DC; Schlafstein AJ; Steuer CE -
Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy device.
Radiother Oncol Volume: 178 Page(s): 109428
01/01/2023 Authors: Henke LE; Fischer-Valuck BW; Rudra S; Wan L; Samson PS; Srivastava A; Gabani P; Roach MC; Zoberi I; Laugeman E